{"id":353696,"date":"2025-08-28T09:40:50","date_gmt":"2025-08-28T09:40:50","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-par-drugs-and-chemicals-limited\/"},"modified":"2025-09-13T07:22:15","modified_gmt":"2025-09-13T07:22:15","slug":"how-to-buy-par-drugs-and-chemicals-limited","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/","title":{"rendered":"How to buy Par Drugs and Chemicals Limited (PAR) shares &#8211; Investment in Par Drugs and Chemicals Limited (PAR) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334018,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-353696","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Par Drugs and Chemicals Limited (PAR) Shares - Investment in Par Drugs and Chemicals Limited (PAR) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Par Drugs and Chemicals Limited (PAR) Shares - Investment in Par Drugs and Chemicals Limited (PAR) Stock"},"description":"Learn how to buy Par Drugs and Chemicals Limited (PAR) shares with current price analysis, risk assessment, and step-by-step investment process for 2025 trading opportunities.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy Par Drugs and Chemicals Limited (PAR) shares with current price analysis, risk assessment, and step-by-step investment process for 2025 trading opportunities."},"intro":"Thinking about investing in India's pharmaceutical sector? Par Drugs and Chemicals Limited offers a unique opportunity in the booming API manufacturing space. With India emerging as a global pharmaceutical powerhouse, this company could be your gateway to capturing growth in one of the world's fastest-growing healthcare markets. Let's explore how you can add PAR to your portfolio.","intro_source":{"label":"Intro","type":"text","formatted_value":"Thinking about investing in India's pharmaceutical sector? Par Drugs and Chemicals Limited offers a unique opportunity in the booming API manufacturing space. With India emerging as a global pharmaceutical powerhouse, this company could be your gateway to capturing growth in one of the world's fastest-growing healthcare markets. Let's explore how you can add PAR to your portfolio."},"body_html":"<h2>\ud83d\udcc8 Understanding Par Drugs and Chemicals Limited Stock Performance<\/h2> <h3>Current Stock Price Analysis<\/h3> <p>As of September 13, 2025, Par Drugs and Chemicals Limited (NSE: PAR) is trading at <strong>Rs. 108.64<\/strong> per share. The stock has experienced significant volatility throughout 2025, hitting a 52-week high of Rs. 348.45 and a 52-week low of Rs. 81.01 (<a href=\"https:\/\/www.icicidirect.com\/stocks\/par-drugs-and-chemicals-ltd-share-price\">ICICI Direct<\/a>). This represents a dramatic 54.22% decline from yearly highs, creating potential opportunities for value investors.<\/p> <h3>Critical Date Alert: November 2025 Earnings Impact<\/h3> <p>Mark your calendar for early November 2025 when Par Drugs releases its next quarterly earnings report. Historical data shows these events typically cause significant price movements. The company's last earnings on August 7, 2025, saw mixed results with sales declining 2.14% year-over-year to Rs. 22.33 crore (<a href=\"https:\/\/blinkx.in\/insights\/history\/par-drugs-chemicals-ltd-share-price-history\">BlinkX Historical Data<\/a>).<\/p> <h3>Historical Earnings Impact Analysis:<\/h3> <table> <thead> <tr><th>Date<\/th><th>Event<\/th><th>Price Change<\/th><th>Outcome<\/th><\/tr> <\/thead> <tbody> <tr><td>Aug 2025<\/td><td>Q2 Earnings<\/td><td>-4.35% (day)<\/td><td>Sales decline<\/td><\/tr> <tr><td>Mar 2025<\/td><td>Q4 Results<\/td><td>+15.22% (month)<\/td><td>Strong recovery<\/td><\/tr> <tr><td>Sep 2024<\/td><td>Previous Quarter<\/td><td>+33.88% YoY<\/td><td>Excellent growth<\/td><\/tr> <\/tbody> <\/table> <p>The pattern suggests earnings reports create excellent entry points, particularly when the market overreacts to temporary setbacks.<\/p> [cta_green text=\"Start trading\"]<h2>\ud83d\udcca 6-Month Price Journey and Trend Analysis<\/h2> <p>Par Drugs shares have shown remarkable resilience despite sector challenges, gaining <strong>7.34% over the past six months<\/strong> (<a href=\"https:\/\/www.icicidirect.com\/stocks\/par-drugs-and-chemicals-ltd-share-price\">ICICI Direct Performance Data<\/a>). Here's the monthly breakdown:<\/p> <ul> <li><strong>March 2025<\/strong>: Rs. 115-125 range - Strong start to the year<\/li> <li><strong>April 2025<\/strong>: Correction phase - Sector-wide concerns<\/li> <li><strong>May 2025<\/strong>: Rs. 95-105 range - Finding support levels<\/li> <li><strong>June 2025<\/strong>: Rs. 85-95 range - Testing yearly lows<\/li> <li><strong>July 2025<\/strong>: Rs. 90-100 range - Initial recovery signs<\/li> <li><strong>August 2025<\/strong>: Rs. 100-110 range - Steady upward momentum<\/li> <li><strong>September 2025<\/strong>: Rs. 105-115 range - Current trading range<\/li> <\/ul> <p>The stock demonstrates classic recovery patterns after hitting oversold conditions in June 2025. The recent bounce from Rs. 81.01 lows suggests strong institutional support at these levels.<\/p> <h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <p>Based on current fundamentals and sector growth projections, here's our realistic price forecast:<\/p> <ul> <li><strong>2025 Year-End<\/strong>: Rs. 125-140 \u2192 <strong>BUY<\/strong> recommendation<br>Strong recovery expected as API demand increases globally<\/li> <li><strong>2026 Forecast<\/strong>: Rs. 150-170<br>Benefiting from India's API manufacturing expansion<\/li> <li><strong>2028 Projection<\/strong>: Rs. 250-300<br>Market leadership consolidation and export growth<\/li> <li><strong>2030 Target<\/strong>: Rs. 400-500<br>Global pharmaceutical supply chain dominance<\/li> <\/ul> <p>These projections align with India's API industry growth rate of 13.7% CAGR and the company's debt-free balance sheet position (<a href=\"https:\/\/api.omrglobal.com\/indias-api-industry-in-2025-rising-powerhouse-amid-global-shifts\/\">OMR Global Industry Report<\/a>).<\/p> <h2>\u26a0\ufe0f Risk Assessment for PAR Investors<\/h2> <h3>Major Risks to Consider:<\/h3> <ul> <li><strong>High Volatility<\/strong>: 52-week range shows extreme price swings (Rs. 81-348)<\/li> <li><strong>Regulatory Dependence<\/strong>: Pharmaceutical sector faces constant regulatory changes<\/li> <li><strong>Export Sensitivity<\/strong>: 40% revenue from exports vulnerable to currency fluctuations<\/li> <li><strong>Competition Pressure<\/strong>: Larger players dominating API manufacturing space<\/li> <li><strong>Raw Material Costs<\/strong>: Chemical input price volatility affects margins<\/li> <\/ul> <h3>Positive Signals for 2025:<\/h3> <ul> <li><strong>Debt-Free Company<\/strong>: Zero debt provides financial flexibility (<a href=\"https:\/\/simplywall.st\/stocks\/in\/pharmaceuticals-biotech\/nse-par\/par-drugs-and-chemicals-shares\">Simply Wall St Analysis<\/a>)<\/li> <li><strong>Industry Tailwinds<\/strong>: India becoming global API hub with 8% market share<\/li> <li><strong>Cost Advantages<\/strong>: 40% lower production costs than Western competitors<\/li> <li><strong>Geopolitical Benefits<\/strong>: China trade tensions benefiting Indian manufacturers<\/li> <li><strong>Strong Margins<\/strong>: 59.80% gross margin indicates pricing power<\/li> <\/ul> <h2>\ud83d\udcf0 Significant News Analysis (Last 6 Months)<\/h2> <h3>Financial Performance Updates:<\/h3> <p>The company reported mixed Q1 2026 results with EPS of Rs. 2.70 versus Rs. 2.06 year-over-year, representing a healthy 31% increase (<a href=\"https:\/\/www.valueresearchonline.com\/stocks\/251559\/par-drugs-and-chemicals-ltd\/\">Value Research Online<\/a>). However, March 2025 quarterly sales declined 2.14% to Rs. 22.33 crore, showing some operational challenges.<\/p> <h3>Operational Efficiency Improvements:<\/h3> <p>Notably, the company reduced its cash conversion cycle to just 15 days as of March 2025, demonstrating excellent working capital management (<a href=\"https:\/\/www.screener.in\/company\/PAR\/\">Screener.in Financials<\/a>). This efficiency gain provides competitive advantage in the capital-intensive pharmaceutical sector.<\/p> <h3>Corporate Governance:<\/h3> <p>The 26th Annual General Meeting scheduled for September 27, 2025, indicates stable management and routine corporate activities without major disruptions (<a href=\"https:\/\/www.tickertape.in\/stocks\/par-drugs-and-chemicals-PARR\">Tickertape Corporate Actions<\/a>).<\/p> <h2>\ud83c\udfaf Beginner Trader Action Plan Today<\/h2> <h3>Serious Recommendations:<\/h3> <ol> <li><strong>Start Small<\/strong>: Begin with 10-20% of your intended position size to test waters<\/li> <li><strong>Wait for Dips<\/strong>: November earnings could provide better entry points below Rs. 100<\/li> <li><strong>Dollar-Cost Average<\/strong>: Spread purchases over 3-6 months to reduce timing risk<\/li> <\/ol> <h3>Humorous Veteran Advice:<\/h3> <p>\"Trading PAR stock is like pharmaceutical manufacturing - sometimes you need to endure the mixing process before seeing the final profitable formula. Don't panic during volatility; these chemicals need time to react properly!\"<\/p> <h2>\u2705 Step-by-Step: How to Buy Par Drugs and Chemicals Limited (PAR) Shares<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose International Broker<\/td><td>Must support NSE\/BSE trading access<\/td><\/tr> <tr><td>2<\/td><td>Complete KYC Verification<\/td><td>PAN card required for Indian market access<\/td><\/tr> <tr><td>3<\/td><td>Fund Your Account<\/td><td>Minimum $50 recommended for initial position<\/td><\/tr> <tr><td>4<\/td><td>Search \"PAR\" Ticker<\/td><td>Use National Stock Exchange symbol<\/td><\/tr> <tr><td>5<\/td><td>Set Limit Order<\/td><td>Avoid market orders during volatile periods<\/td><\/tr> <tr><td>6<\/td><td>Monitor Position<\/td><td>Pharmaceutical stocks need active management<\/td><\/tr> <tr><td>7<\/td><td>Set Stop-Loss<\/td><td>Protect against extreme volatility<\/td><\/tr> <tr><td>8<\/td><td>Review Quarterly<\/td><td>Earnings reports drive major price movements<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Why Pocket Option Excels for New Investors<\/h2> <p>Pocket Option revolutionizes stock trading accessibility with features perfectly suited for PAR investment:<\/p> <ul> <li><strong>Minimum Deposit Advantage<\/strong>: Only $5 required to start trading, making it ideal for testing strategies with Par Drugs shares without significant capital commitment (<a href=\"https:\/\/pocketoption.com\/blog\/en\/interesting\/trading-platforms\/what-is-the-minimum-deposit-in-pocket-option\/\">Pocket Option Deposit Guide<\/a>).<\/li> <li><strong>Lightning-Fast Verification<\/strong>: Complete KYC in minutes using any single identification document, getting you market-ready when opportunities arise.<\/li> <li><strong>Diverse Withdrawal Options<\/strong>: Over 100 withdrawal methods including cryptocurrencies, e-wallets, and traditional banking, ensuring you can access profits from successful PAR trades conveniently.<\/li> <\/ul> <p>The platform's user-friendly interface combined with professional charting tools makes analyzing Par Drugs' technical patterns straightforward even for beginners.<\/p> <h2>\ud83c\udfed Company Overview: Par Drugs in 2025<\/h2> <p>Par Drugs and Chemicals Limited stands as a established player in India's pharmaceutical ingredients sector, operating since 1999 with manufacturing facilities in Bhavnagar and Ankleshwar, Gujarat. The company specializes in producing 15 active pharmaceutical ingredients (APIs) and 10 fine chemicals serving both domestic and international markets (<a href=\"https:\/\/www.moneycontrol.com\/india\/stockpricequote\/chemicals\/pardrugschemicals\/PDC02\">Moneycontrol Company Profile<\/a>).<\/p> <h3>Current Market Position:<\/h3> <ul> <li>Market Cap: Rs. 133.68 crore<\/li> <li>P\/E Ratio: 9.87 (undervalued relative to sector)<\/li> <li>P\/B Ratio: 1.41 (reasonable valuation)<\/li> <li>Debt: Zero debt - financially stable<\/li> <\/ul> <h3>Product Portfolio Includes:<\/h3> <ul> <li>Magnesium hydroxide and oxide products<\/li> <li>Sucralfate and almagate BP<\/li> <li>Various magnesium compounds<\/li> <li>Pharmaceutical-grade chemicals<\/li> <\/ul> <h3>Interesting Fact for 2025:<\/h3> <p>Par Drugs operates in a sector where India now supplies 57% of APIs to the World Health Organization's prequalified list, making companies like PAR crucial players in global healthcare supply chains (<a href=\"https:\/\/api.omrglobal.com\/indias-api-industry-in-2025-rising-powerhouse-amid-global-shifts\/\">Global API Market Report<\/a>). This positions them perfectly for the increasing global demand for reliable pharmaceutical ingredients.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 Understanding Par Drugs and Chemicals Limited Stock Performance<\/h2>\n<h3>Current Stock Price Analysis<\/h3>\n<p>As of September 13, 2025, Par Drugs and Chemicals Limited (NSE: PAR) is trading at <strong>Rs. 108.64<\/strong> per share. The stock has experienced significant volatility throughout 2025, hitting a 52-week high of Rs. 348.45 and a 52-week low of Rs. 81.01 (<a href=\"https:\/\/www.icicidirect.com\/stocks\/par-drugs-and-chemicals-ltd-share-price\">ICICI Direct<\/a>). This represents a dramatic 54.22% decline from yearly highs, creating potential opportunities for value investors.<\/p>\n<h3>Critical Date Alert: November 2025 Earnings Impact<\/h3>\n<p>Mark your calendar for early November 2025 when Par Drugs releases its next quarterly earnings report. Historical data shows these events typically cause significant price movements. The company&#8217;s last earnings on August 7, 2025, saw mixed results with sales declining 2.14% year-over-year to Rs. 22.33 crore (<a href=\"https:\/\/blinkx.in\/insights\/history\/par-drugs-chemicals-ltd-share-price-history\">BlinkX Historical Data<\/a>).<\/p>\n<h3>Historical Earnings Impact Analysis:<\/h3>\n<table>\n<thead>\n<tr>\n<th>Date<\/th>\n<th>Event<\/th>\n<th>Price Change<\/th>\n<th>Outcome<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Aug 2025<\/td>\n<td>Q2 Earnings<\/td>\n<td>-4.35% (day)<\/td>\n<td>Sales decline<\/td>\n<\/tr>\n<tr>\n<td>Mar 2025<\/td>\n<td>Q4 Results<\/td>\n<td>+15.22% (month)<\/td>\n<td>Strong recovery<\/td>\n<\/tr>\n<tr>\n<td>Sep 2024<\/td>\n<td>Previous Quarter<\/td>\n<td>+33.88% YoY<\/td>\n<td>Excellent growth<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The pattern suggests earnings reports create excellent entry points, particularly when the market overreacts to temporary setbacks.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca 6-Month Price Journey and Trend Analysis<\/h2>\n<p>Par Drugs shares have shown remarkable resilience despite sector challenges, gaining <strong>7.34% over the past six months<\/strong> (<a href=\"https:\/\/www.icicidirect.com\/stocks\/par-drugs-and-chemicals-ltd-share-price\">ICICI Direct Performance Data<\/a>). Here&#8217;s the monthly breakdown:<\/p>\n<ul>\n<li><strong>March 2025<\/strong>: Rs. 115-125 range &#8211; Strong start to the year<\/li>\n<li><strong>April 2025<\/strong>: Correction phase &#8211; Sector-wide concerns<\/li>\n<li><strong>May 2025<\/strong>: Rs. 95-105 range &#8211; Finding support levels<\/li>\n<li><strong>June 2025<\/strong>: Rs. 85-95 range &#8211; Testing yearly lows<\/li>\n<li><strong>July 2025<\/strong>: Rs. 90-100 range &#8211; Initial recovery signs<\/li>\n<li><strong>August 2025<\/strong>: Rs. 100-110 range &#8211; Steady upward momentum<\/li>\n<li><strong>September 2025<\/strong>: Rs. 105-115 range &#8211; Current trading range<\/li>\n<\/ul>\n<p>The stock demonstrates classic recovery patterns after hitting oversold conditions in June 2025. The recent bounce from Rs. 81.01 lows suggests strong institutional support at these levels.<\/p>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<p>Based on current fundamentals and sector growth projections, here&#8217;s our realistic price forecast:<\/p>\n<ul>\n<li><strong>2025 Year-End<\/strong>: Rs. 125-140 \u2192 <strong>BUY<\/strong> recommendation<br \/>Strong recovery expected as API demand increases globally<\/li>\n<li><strong>2026 Forecast<\/strong>: Rs. 150-170<br \/>Benefiting from India&#8217;s API manufacturing expansion<\/li>\n<li><strong>2028 Projection<\/strong>: Rs. 250-300<br \/>Market leadership consolidation and export growth<\/li>\n<li><strong>2030 Target<\/strong>: Rs. 400-500<br \/>Global pharmaceutical supply chain dominance<\/li>\n<\/ul>\n<p>These projections align with India&#8217;s API industry growth rate of 13.7% CAGR and the company&#8217;s debt-free balance sheet position (<a href=\"https:\/\/api.omrglobal.com\/indias-api-industry-in-2025-rising-powerhouse-amid-global-shifts\/\">OMR Global Industry Report<\/a>).<\/p>\n<h2>\u26a0\ufe0f Risk Assessment for PAR Investors<\/h2>\n<h3>Major Risks to Consider:<\/h3>\n<ul>\n<li><strong>High Volatility<\/strong>: 52-week range shows extreme price swings (Rs. 81-348)<\/li>\n<li><strong>Regulatory Dependence<\/strong>: Pharmaceutical sector faces constant regulatory changes<\/li>\n<li><strong>Export Sensitivity<\/strong>: 40% revenue from exports vulnerable to currency fluctuations<\/li>\n<li><strong>Competition Pressure<\/strong>: Larger players dominating API manufacturing space<\/li>\n<li><strong>Raw Material Costs<\/strong>: Chemical input price volatility affects margins<\/li>\n<\/ul>\n<h3>Positive Signals for 2025:<\/h3>\n<ul>\n<li><strong>Debt-Free Company<\/strong>: Zero debt provides financial flexibility (<a href=\"https:\/\/simplywall.st\/stocks\/in\/pharmaceuticals-biotech\/nse-par\/par-drugs-and-chemicals-shares\">Simply Wall St Analysis<\/a>)<\/li>\n<li><strong>Industry Tailwinds<\/strong>: India becoming global API hub with 8% market share<\/li>\n<li><strong>Cost Advantages<\/strong>: 40% lower production costs than Western competitors<\/li>\n<li><strong>Geopolitical Benefits<\/strong>: China trade tensions benefiting Indian manufacturers<\/li>\n<li><strong>Strong Margins<\/strong>: 59.80% gross margin indicates pricing power<\/li>\n<\/ul>\n<h2>\ud83d\udcf0 Significant News Analysis (Last 6 Months)<\/h2>\n<h3>Financial Performance Updates:<\/h3>\n<p>The company reported mixed Q1 2026 results with EPS of Rs. 2.70 versus Rs. 2.06 year-over-year, representing a healthy 31% increase (<a href=\"https:\/\/www.valueresearchonline.com\/stocks\/251559\/par-drugs-and-chemicals-ltd\/\">Value Research Online<\/a>). However, March 2025 quarterly sales declined 2.14% to Rs. 22.33 crore, showing some operational challenges.<\/p>\n<h3>Operational Efficiency Improvements:<\/h3>\n<p>Notably, the company reduced its cash conversion cycle to just 15 days as of March 2025, demonstrating excellent working capital management (<a href=\"https:\/\/www.screener.in\/company\/PAR\/\">Screener.in Financials<\/a>). This efficiency gain provides competitive advantage in the capital-intensive pharmaceutical sector.<\/p>\n<h3>Corporate Governance:<\/h3>\n<p>The 26th Annual General Meeting scheduled for September 27, 2025, indicates stable management and routine corporate activities without major disruptions (<a href=\"https:\/\/www.tickertape.in\/stocks\/par-drugs-and-chemicals-PARR\">Tickertape Corporate Actions<\/a>).<\/p>\n<h2>\ud83c\udfaf Beginner Trader Action Plan Today<\/h2>\n<h3>Serious Recommendations:<\/h3>\n<ol>\n<li><strong>Start Small<\/strong>: Begin with 10-20% of your intended position size to test waters<\/li>\n<li><strong>Wait for Dips<\/strong>: November earnings could provide better entry points below Rs. 100<\/li>\n<li><strong>Dollar-Cost Average<\/strong>: Spread purchases over 3-6 months to reduce timing risk<\/li>\n<\/ol>\n<h3>Humorous Veteran Advice:<\/h3>\n<p>&#8220;Trading PAR stock is like pharmaceutical manufacturing &#8211; sometimes you need to endure the mixing process before seeing the final profitable formula. Don&#8217;t panic during volatility; these chemicals need time to react properly!&#8221;<\/p>\n<h2>\u2705 Step-by-Step: How to Buy Par Drugs and Chemicals Limited (PAR) Shares<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose International Broker<\/td>\n<td>Must support NSE\/BSE trading access<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete KYC Verification<\/td>\n<td>PAN card required for Indian market access<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Fund Your Account<\/td>\n<td>Minimum $50 recommended for initial position<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Search &#8220;PAR&#8221; Ticker<\/td>\n<td>Use National Stock Exchange symbol<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Set Limit Order<\/td>\n<td>Avoid market orders during volatile periods<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Monitor Position<\/td>\n<td>Pharmaceutical stocks need active management<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Set Stop-Loss<\/td>\n<td>Protect against extreme volatility<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Review Quarterly<\/td>\n<td>Earnings reports drive major price movements<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Excels for New Investors<\/h2>\n<p>Pocket Option revolutionizes stock trading accessibility with features perfectly suited for PAR investment:<\/p>\n<ul>\n<li><strong>Minimum Deposit Advantage<\/strong>: Only $5 required to start trading, making it ideal for testing strategies with Par Drugs shares without significant capital commitment (<a href=\"https:\/\/pocketoption.com\/blog\/en\/interesting\/trading-platforms\/what-is-the-minimum-deposit-in-pocket-option\/\">Pocket Option Deposit Guide<\/a>).<\/li>\n<li><strong>Lightning-Fast Verification<\/strong>: Complete KYC in minutes using any single identification document, getting you market-ready when opportunities arise.<\/li>\n<li><strong>Diverse Withdrawal Options<\/strong>: Over 100 withdrawal methods including cryptocurrencies, e-wallets, and traditional banking, ensuring you can access profits from successful PAR trades conveniently.<\/li>\n<\/ul>\n<p>The platform&#8217;s user-friendly interface combined with professional charting tools makes analyzing Par Drugs&#8217; technical patterns straightforward even for beginners.<\/p>\n<h2>\ud83c\udfed Company Overview: Par Drugs in 2025<\/h2>\n<p>Par Drugs and Chemicals Limited stands as a established player in India&#8217;s pharmaceutical ingredients sector, operating since 1999 with manufacturing facilities in Bhavnagar and Ankleshwar, Gujarat. The company specializes in producing 15 active pharmaceutical ingredients (APIs) and 10 fine chemicals serving both domestic and international markets (<a href=\"https:\/\/www.moneycontrol.com\/india\/stockpricequote\/chemicals\/pardrugschemicals\/PDC02\">Moneycontrol Company Profile<\/a>).<\/p>\n<h3>Current Market Position:<\/h3>\n<ul>\n<li>Market Cap: Rs. 133.68 crore<\/li>\n<li>P\/E Ratio: 9.87 (undervalued relative to sector)<\/li>\n<li>P\/B Ratio: 1.41 (reasonable valuation)<\/li>\n<li>Debt: Zero debt &#8211; financially stable<\/li>\n<\/ul>\n<h3>Product Portfolio Includes:<\/h3>\n<ul>\n<li>Magnesium hydroxide and oxide products<\/li>\n<li>Sucralfate and almagate BP<\/li>\n<li>Various magnesium compounds<\/li>\n<li>Pharmaceutical-grade chemicals<\/li>\n<\/ul>\n<h3>Interesting Fact for 2025:<\/h3>\n<p>Par Drugs operates in a sector where India now supplies 57% of APIs to the World Health Organization&#8217;s prequalified list, making companies like PAR crucial players in global healthcare supply chains (<a href=\"https:\/\/api.omrglobal.com\/indias-api-industry-in-2025-rising-powerhouse-amid-global-shifts\/\">Global API Market Report<\/a>). This positions them perfectly for the increasing global demand for reliable pharmaceutical ingredients.<\/p>\n"},"faq":[{"question":"What is the minimum investment required for PAR shares?","answer":"You can start with as little as $50 through most international brokers, though $200-500 provides better position sizing for risk management."},{"question":"How often does Par Drugs pay dividends?","answer":"The company has inconsistent dividend history. Focus on capital appreciation rather than dividend income with this growth stock."},{"question":"Is now a good time to buy PAR shares?","answer":"Current prices near yearly lows offer attractive entry points, but consider waiting for November earnings for potential better prices."},{"question":"What are the main competitors to Par Drugs?","answer":"Larger API manufacturers like Divi's Laboratories, Sun Pharmaceutical, and Dr. Reddy's dominate the space, but PAR occupies a niche position."},{"question":"How can I track PAR stock performance daily?","answer":"Use financial platforms like Moneycontrol, Tickertape, or your broker's mobile app with price alerts set for key levels."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"What is the minimum investment required for PAR shares?","answer":"You can start with as little as $50 through most international brokers, though $200-500 provides better position sizing for risk management."},{"question":"How often does Par Drugs pay dividends?","answer":"The company has inconsistent dividend history. Focus on capital appreciation rather than dividend income with this growth stock."},{"question":"Is now a good time to buy PAR shares?","answer":"Current prices near yearly lows offer attractive entry points, but consider waiting for November earnings for potential better prices."},{"question":"What are the main competitors to Par Drugs?","answer":"Larger API manufacturers like Divi's Laboratories, Sun Pharmaceutical, and Dr. Reddy's dominate the space, but PAR occupies a niche position."},{"question":"How can I track PAR stock performance daily?","answer":"Use financial platforms like Moneycontrol, Tickertape, or your broker's mobile app with price alerts set for key levels."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Par Drugs and Chemicals Limited (PAR) shares - Investment in Par Drugs and Chemicals Limited (PAR) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Par Drugs and Chemicals Limited (PAR) shares - Investment in Par Drugs and Chemicals Limited (PAR) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-28T09:40:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-13T07:22:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"576\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Par Drugs and Chemicals Limited (PAR) shares &#8211; Investment in Par Drugs and Chemicals Limited (PAR) stock\",\"datePublished\":\"2025-08-28T09:40:50+00:00\",\"dateModified\":\"2025-09-13T07:22:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/\",\"name\":\"How to buy Par Drugs and Chemicals Limited (PAR) shares - Investment in Par Drugs and Chemicals Limited (PAR) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"datePublished\":\"2025-08-28T09:40:50+00:00\",\"dateModified\":\"2025-09-13T07:22:15+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Par Drugs and Chemicals Limited (PAR) shares &#8211; Investment in Par Drugs and Chemicals Limited (PAR) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Par Drugs and Chemicals Limited (PAR) shares - Investment in Par Drugs and Chemicals Limited (PAR) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Par Drugs and Chemicals Limited (PAR) shares - Investment in Par Drugs and Chemicals Limited (PAR) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-28T09:40:50+00:00","article_modified_time":"2025-09-13T07:22:15+00:00","og_image":[{"width":1024,"height":576,"url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals11.webp","type":"image\/webp"}],"author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Par Drugs and Chemicals Limited (PAR) shares &#8211; Investment in Par Drugs and Chemicals Limited (PAR) stock","datePublished":"2025-08-28T09:40:50+00:00","dateModified":"2025-09-13T07:22:15+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/","name":"How to buy Par Drugs and Chemicals Limited (PAR) shares - Investment in Par Drugs and Chemicals Limited (PAR) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","datePublished":"2025-08-28T09:40:50+00:00","dateModified":"2025-09-13T07:22:15+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Par Drugs and Chemicals Limited (PAR) shares &#8211; Investment in Par Drugs and Chemicals Limited (PAR) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":353858,"slug":"how-to-buy-par-drugs-and-chemicals-limited","post_title":"Comment acheter des actions Par Drugs and Chemicals Limited (PAR) - Investissement dans les actions Par Drugs and Chemicals Limited (PAR)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/"},"it_IT":{"locale":"it_IT","id":353857,"slug":"how-to-buy-par-drugs-and-chemicals-limited","post_title":"Come acquistare azioni Par Drugs and Chemicals Limited (PAR) - Investimento in azioni Par Drugs and Chemicals Limited (PAR)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/"},"pl_PL":{"locale":"pl_PL","id":353859,"slug":"how-to-buy-par-drugs-and-chemicals-limited","post_title":"Jak kupi\u0107 akcje Par Drugs and Chemicals Limited (PAR) - Inwestycja w akcje Par Drugs and Chemicals Limited (PAR)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/"},"es_ES":{"locale":"es_ES","id":353860,"slug":"how-to-buy-par-drugs-and-chemicals-limited","post_title":"C\u00f3mo comprar acciones de Par Drugs and Chemicals Limited (PAR) - Inversi\u00f3n en acciones de Par Drugs and Chemicals Limited (PAR)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/"},"th_TH":{"locale":"th_TH","id":353862,"slug":"how-to-buy-par-drugs-and-chemicals-limited","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Par Drugs and Chemicals Limited (PAR) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Par Drugs and Chemicals Limited (PAR)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/"},"tr_TR":{"locale":"tr_TR","id":353863,"slug":"how-to-buy-par-drugs-and-chemicals-limited","post_title":"Par Drugs and Chemicals Limited (PAR) Hisseleri Nas\u0131l Al\u0131n\u0131r - Par Drugs and Chemicals Limited (PAR) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/"},"vt_VT":{"locale":"vt_VT","id":353861,"slug":"how-to-buy-par-drugs-and-chemicals-limited","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Par Drugs and Chemicals Limited (PAR) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Par Drugs and Chemicals Limited (PAR)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/"},"pt_AA":{"locale":"pt_AA","id":353864,"slug":"how-to-buy-par-drugs-and-chemicals-limited","post_title":"Como comprar a\u00e7\u00f5es da Par Drugs and Chemicals Limited (PAR) - Investimento em a\u00e7\u00f5es da Par Drugs and Chemicals Limited (PAR)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-par-drugs-and-chemicals-limited\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/353696","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=353696"}],"version-history":[{"count":1,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/353696\/revisions"}],"predecessor-version":[{"id":373785,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/353696\/revisions\/373785"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334018"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=353696"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=353696"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=353696"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}